BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30

• Drug Development

  ASCO2016: Tyrogenex, Inc. Presents Data Informing Phase II And Supporting Potential Efficacy Of X-82 With Everolimus In Patients With Solid Tumors At The ASCO Annual Meeting 2016

  June 6, 2016

   · 

  2 min read
• Drug Development

  ASCO2016: Xcovery Presents Results Of Plasma Genotyping Of Patients In The Exalt2 Study At The ASCO Annual Meeting 2016

  June 6, 2016

   · 

  4 min read
• Drug Development

  ASCO2016: Bristol-Myers Squibb Release: First Presentation Of Phase II Checkmate -142 Study Evaluating Opdivo (Nivolumab) Alone Or In Combination With Yervoy (Ipilimumab) Demonstrates Encouraging Clinical Activity In MSI-High Metastatic Colorectal Cancer

  June 6, 2016

   · 

  19 min read
• Drug Development

  IgASCO2016: Ignyta Announces Interim Data From Phase 1 Clinical Trial Of Investigational Precision Medicine RXDX-105 At ASCO 2016

  June 6, 2016

   · 

  7 min read
• Drug Development

  ASCO2016: Puma Biotech Presents Positive Phase II Data At The 2016 ASCO Annual Meeting

  June 6, 2016

   · 

  6 min read
• Drug Development

  ASCO2016: Pfizer Presents Data From Phase Ib Trial Investigating Utomilumab (A 4-1BB Agonist) In Combination With A Checkpoint Inhibitor

  June 6, 2016

   · 

  8 min read
• Business

  Fujifilm Diosynth Biotechnologies Announces Collaboration On A New 20,000-Liter Microbial Biologics Facility For Use By Its Contract Development And Manufacturing Customers

  June 6, 2016

   · 

  3 min read
• Genetown

  ASCO2016: Foundation Medicine, Inc. Release: FoundationOne Identifies Patients With Advanced Lung Cancer Likely To Respond Or Develop Resistance To Certain RET Inhibitor Therapies

  June 6, 2016

   · 

  7 min read
• BioMidwest

  Polaris Group Release: FLT-PET Scan Provides Early Evidence Of Response To Arginine Depletion By ADI-PEG 20 In Argininosuccinate Synthetase Deficient Thoracic Tumors

  June 6, 2016

   · 

  2 min read
• Drug Development

  Polaris Group Reports Phase III Study Results Of ADI-PEG 20 Plus Best Supportive Care In Advanced Hepatocellular Carcinoma

  June 6, 2016

   · 

  3 min read